Key result
Preliminary results from clinical trials investigating interference between wireless technology and implanted cardiac pacemakers have shown the need for carrying out risk management steps.
The WTR program is developing risk management strategies to address interference between wireless technology and implanted cardiac pacemakers.
May warrant interim risk management for wireless interference in pacemaker patients; leaves open confirmation from completed trials.
Besides assessing potential health risks, another of the Wireless Technology Research, L.L.C. (WTR) program's goals is to identify interventions to mitigate such risks should they be identified and to decide on the appropriate strategies to carry out those interventions. The risk management research is being coordinated through six working groups: (1) product certification, (2) product labeling, (3) product design changes, (4) infrastructure modifications, (5) usage restrictions, and (6) education and scientific outreach. Each working group is developing intervention strategies specific to their area. Working group members include scientists and engineers from the WTR, industry, and academia. As the risk evaluation surveillance component of the program proceeds, the WTR continually evaluates all new data relevant to wireless technology and its public health impact Preliminary results from the WTR‐sponsored clinical trials investigating interference between wireless technology and implanted cardiac pacemakers have shown the need for carrying out risk management steps. The WTR has organized a committee to direct this risk management research and use the resulting data to draft risk management recommendations. The other risk management research working groups will continue their effort throughout the project to develop data that will bring decision makers to a state of readiness regarding risk management.
No takes yet. Share an insight, caveat, or question.
Embrey et al. (1997) conducted a review in Interference between wireless technology and implanted cardiac pacemakers. Wireless technology risk management was evaluated. Preliminary results from clinical trials investigating interference between wireless technology and implanted cardiac pacemakers have shown the need for carrying out risk management steps.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: